Brief: Bone Biologics Receives Human Research Ethics Committee Approval To Begin Pilot Clinical Trial With Nb1 In Spinal Fusion Patients In Australia

Bone Biologics

11/04/2023 13:19

April 11 (Reuters) - Bone Biologics Corp  BBLG.O :
    * BONE BIOLOGICS RECEIVES HUMAN RESEARCH ETHICS COMMITTEE
APPROVAL
TO BEGIN PILOT CLINICAL TRIAL WITH NB1 IN SPINAL FUSION PATIENTS
IN AUSTRALIA
    * BONE BIOLOGICS CORP - PLANS TO BEGIN 30-PATIENT TRIAL OF
NB1
LATER THIS YEAR

Source text for Eikon:  ID:nBwblV0pCa 
Further company coverage:  BBLG.O 

 ((Reuters.Briefs@thomsonreuters.com;))